Cephalon Inc Sample Contracts

NOVARTIS PHARMACEUTICALS UK LIMITED DISTRIBUTION AGREEMENT
Distribution Agreement • March 30th, 2001 • Cephalon Inc • Pharmaceutical preparations • England
AutoNDA by SimpleDocs
RECITALS
Merger Agreement • July 21st, 2000 • Cephalon Inc • Pharmaceutical preparations • Delaware
INDENTURE DATED AS OF DECEMBER 11, 2001 STATE STREET BANK AND TRUST COMPANY, AS TRUSTEE
Indenture • February 14th, 2002 • Cephalon Inc • Pharmaceutical preparations • New York
EXHIBIT 4.2 CEPHALON, INC. 2 1/2% CONVERTIBLE SUBORDINATED NOTES DUE DECEMBER 15, 2006 REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • February 14th, 2002 • Cephalon Inc • Pharmaceutical preparations • New York
FIRST AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT
Rights Agreement • August 2nd, 2000 • Cephalon Inc • Pharmaceutical preparations • Delaware
RECITALS
Merger Agreement • October 18th, 2000 • Cephalon Inc • Pharmaceutical preparations • Delaware
and
Rights Agreement • January 20th, 1999 • Cephalon Inc • Pharmaceutical preparations • Delaware
CREDIT AGREEMENT dated as of August 15, 2008, among CEPHALON, INC., as Borrower, The Lenders Party Hereto
Credit Agreement • August 18th, 2008 • Cephalon Inc • Pharmaceutical preparations • New York

CREDIT AGREEMENT dated as of August 15, 2008, among CEPHALON, INC., a Delaware corporation (the “Borrower”), the LENDERS party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.

ISDA(R) International Swap Dealers Association, Inc.
Isda Master Agreement • April 9th, 1997 • Cephalon Inc • Pharmaceutical preparations • New York
COLLABORATION AGREEMENT
Collaboration Agreement • March 30th, 2001 • Cephalon Inc • Pharmaceutical preparations • England
January 21, 1998 Genelco S.A. 8 Route de Beaumont 1701 Fribourg Switzerland Re: Amendment No. 3 to Trademark License Agreement Gentlemen: This letter shall serve as an amendment to that certain Trademark Agreement dated as of January 20, 1993, as...
Trademark License Agreement • May 24th, 1999 • Cephalon Inc • Pharmaceutical preparations

This letter shall serve as an amendment to that certain Trademark Agreement dated as of January 20, 1993, as amended (the "Trademark Agreement"), between Cephalon, Inc. (hereinafter "Cephalon") and Genelco S.A. (hereinafter "Genelco"). Unless otherwise defined herein, all capitalized terms shall have the meanings ascribed to them in the Trademark Agreement.

AutoNDA by SimpleDocs
EXHIBIT 4.3a NOTE PURCHASE AGREEMENTS DATED FEBRUARY 24, 1999 BETWEEN CEPHALON, INC. AND THE FOLLOWING INVESTORS
Note Purchase Agreement • July 19th, 1999 • Cephalon Inc • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • November 14th, 2011 • Cephalon Inc • Pharmaceutical preparations

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of October 6, 2011, among Q HOLDINGS, INC., a Delaware corporation (the “Company”), and each signatory hereto (each, an “Investor” and collectively, the “Investors”).

WITNESSETH
Patent and Trademark Security Agreement • March 4th, 1999 • Cephalon Inc • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • December 21st, 2004 • Cephalon Inc • Pharmaceutical preparations • New York

Cephalon, Inc., a Delaware corporation (the “Company”) proposes to offer to holders (the “Holders”) of its outstanding $375,000,000 of Zero Coupon Convertible Subordinated Notes due June 15, 2033, First Putable June 15, 2008 and its outstanding $375,000,000 of Zero Coupon Convertible Subordinated Notes due June 15, 2033, First Putable June 15, 2010 (collectively, the “Existing Securities”) to exchange in an exchange offer (the “Exchange Offer”) new securities (the “New Securities”) for any and all of its Existing Securities. The New Securities will be convertible into shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”) at the conversion price set forth in the Offer to Exchange dated November 16, 2004 (the “Offer to Exchange”). The New Securities will be issued pursuant to an Indenture, dated as of December 20, 2004 (the “Indenture”), among the Company and U.S. Bank National Association, as trustee (the “Trustee”). The Company hereby agrees for the ben

AND -
Managed Services Agreement • March 30th, 2001 • Cephalon Inc • Pharmaceutical preparations • England
MASTER AGREEMENT dated as of January 22, 2003
Master Agreement • May 15th, 2003 • Cephalon Inc • Pharmaceutical preparations • New York

Credit Suisse First Boston and Cephalon Inc. have entered and/or anticipate entering into one or more transactions (each a "Transaction") that are or will be governed by this Master Agreement, which includes the schedule (the "Schedule"), and the documents and other confirming evidence (each a "Confirmation") exchanged between the parties confirming those Transactions.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!